Chemo Lecture 6: Targeted Therapy and biologicals Flashcards
MOA and therapeutic use of imatinib
- Imatinib occupies the ATP cofactor binding sites on Bcr, Abl fusion gene of CML, inhibiting transfer of phosphate to tyrosine on substrates.
- GIST ( imatinib inhibits c-kit and PDGFR)
Therapeutic use of Dasatinib
- primary and imatinib resistant CML (inhibits bcr-abl)
- GIST (dasatinib inhibits Src family)
Mechanism of imatinib resistance
- mutation of ATP binding pocket to exlcude imatinib
- Dasatinib can overcome imatinib resistance
Main adverse effects of imatinib
many drug interactions due to hepatic CYP450. Agents that induce CYP450 (e.g. st johns wort, rifampin) hasten clearance of imatinib
List drugs that are membrane associated receptor tyrosine kinase inhibitors
- Gefitnib
- Erlotinib
- Lapatinib
- Sunitinib
- Sorafenib
Erlotinib and gefitinib target which receptor and thus is useful for what cancer?
Blocks EGFR, useful for NSCLC
Lapatinib blocks what receptors and thus is useful for what cancer?
EGFR and HER2, useful for breast cancer
Sunitinib blocks what receptors and thus are useful for what cancers
Blocks C-kit, PDGFR, VEGFR, useful for GIST and RCC
Sorafenib blocks what receptor and thus used for what cancer?
blocks PDGFR and VEGFR, useful for RCC and HCC
What drug blocks mutated form of BRAF kinase (V600E), and used for what cancer?
Vemurafenib, used for melanoma
which antibodies target EGFR
Cetuximab and panitumumab
Which antibody target HER2
Transtuzumab
Which antibody targets VEGF?
Bevacizumab
What is cetuximab used for?
Colorectal; head and neck cancers
What is panitumumab used for?
Colorectal cancer (w/o KRAS mutation)